Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

By News Health
1 month Ago

(MedPage Today) — In acute coronary syndrome (ACS), a prasugrel (Effient)-based antiplatelet regimen passed muster for reducing bleeding without compromising ischemic protection after percutaneous coronary intervention (PCI).
4D-ACS trial investigators…

Source link : https://www.medpagetoday.com/meetingcoverage/europcr/115729

Author :

Publish date : 2025-05-22 21:19:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

At-home HPV test kits to be offered to thousands of women in England

Datroway Gains Second FDA Nod With NSCLC Approval

AID Systems Need Upgrades for Premenopausal Glucose Control

Metabolic Syndrome and Psoriatic Arthritis: Common but Unwanted Bedfellows

CMS Tightens Reins on Obamacare Access

Test Predicts Cognitive Decline in Parkinson's Disease